SVB Wealth’s IDEAYA Biosciences IDYA Stock Holding History

SVB Wealth’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19	Closed	-$311	–	1024
2025 Q1	$311	Buy	+19	New	+$405	﹤0.01%	1444

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SVB Wealth's IDYA Position: Q2 2025 in Review

SVB Wealth sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 19 shares — an estimated $311 sold.

SVB Wealth first reported a position in IDYA in Q1 2025 and held it in 1 quarter. The position peaked at $311 in Q1 2025. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

SVB Wealth reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 19 IDEAYA Biosciences shares in Q2 2025, an estimated $311.
SVB Wealth first reported a position in IDEAYA Biosciences in Q1 2025 and held it in 1 quarter.
SVB Wealth's IDEAYA Biosciences position peaked at $311 in Q1 2025.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.